Cross-calibration of two dual-energy X-ray absorptiometry devices for the measurement of body composition in young children.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 08 2022
Historique:
received: 26 04 2022
accepted: 29 07 2022
entrez: 16 8 2022
pubmed: 17 8 2022
medline: 19 8 2022
Statut: epublish

Résumé

This study aimed to cross-calibrate body composition measures from the GE Lunar Prodigy and GE Lunar iDXA in a cohort of young children. 28 children (mean age 3.4 years) were measured on the iDXA followed by the Prodigy. Prodigy scans were subsequently reanalysed using enCORE v17 enhanced analysis ("Prodigy enhanced"). Body composition parameters were compared across three evaluation methods (Prodigy, Prodigy enhanced, iDXA), and adjustment equations were developed. There were differences in the three evaluation methods for all body composition parameters. Body fat percentage (%BF) from the iDXA was approximately 1.5-fold greater than the Prodigy, whereas bone mineral density (BMD) was approximately 20% lower. Reanalysis of Prodigy scans with enhanced software attenuated these differences (%BF: - 5.2% [95% CI - 3.5, - 6.8]; and BMD: 1.0% [95% CI 0.0, 1.9]), although significant differences remained for all parameters except total body less head (TBLH) total mass and TBLH BMD, and some regional estimates. There were large differences between the Prodigy and iDXA, with these differences related both to scan resolution and software. Reanalysis of Prodigy scans with enhanced analysis resulted in body composition values much closer to those obtained on the iDXA, although differences remained. As manufacturers update models and software, researchers and clinicians need to be aware of the impact this may have on the longitudinal assessment of body composition, as results may not be comparable across devices and software versions.

Identifiants

pubmed: 35974044
doi: 10.1038/s41598-022-17711-0
pii: 10.1038/s41598-022-17711-0
pmc: PMC9381538
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13862

Subventions

Organisme : Department of Health
ID : 17/63/154
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/17/3174
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_21022
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-12-15-20004
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_21001
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_21003
Pays : United Kingdom
Organisme : Department of Health
ID : NF-SI-0515-10042
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Poult Sci. 2019 Jun 1;98(6):2652-2661
pubmed: 30839076
J Clin Densitom. 2017 Oct - Dec;20(4):498-506
pubmed: 28756995
J Clin Densitom. 2021 Jul-Sep;24(3):481-489
pubmed: 33454177
Am J Physiol. 1996 Dec;271(6 Pt 1):E941-51
pubmed: 8997211
Bone. 2022 Jul;160:116415
pubmed: 35398588
J Bone Miner Res. 2017 Jan;32(1):172-180
pubmed: 27490028
J Clin Densitom. 2015 Jan-Mar;18(1):86-92
pubmed: 24120577
Animal. 2021 Aug;15(8):100307
pubmed: 34273875
Am J Hum Biol. 2014 May-Jun;26(3):291-304
pubmed: 24424686
Obesity (Silver Spring). 2008 Feb;16(2):457-62
pubmed: 18239659
J Clin Densitom. 2020 Jan - Mar;23(1):128-137
pubmed: 30981615
J Clin Densitom. 2019 Oct - Dec;22(4):453-471
pubmed: 31400968
Calcif Tissue Int. 1996 Jul;59(1):1-5
pubmed: 8661987
J Clin Densitom. 2018 Jul - Sep;21(3):383-393
pubmed: 28732577
Pediatr Res. 1997 Apr;41(4 Pt 1):590-6
pubmed: 9098865
Trials. 2017 Mar 20;18(1):131
pubmed: 28320484
Pediatr Obes. 2016 Aug;11(4):264-71
pubmed: 26198967
J Am Coll Nutr. 2004 Jun;23(3):212-9
pubmed: 15190045
Obes Rev. 2020 Aug;21(8):e13033
pubmed: 32314544
J Clin Densitom. 2016 Jul-Sep;19(3):290-7
pubmed: 26209017
Obesity (Silver Spring). 2012 Jan;20(1):30-9
pubmed: 21760631

Auteurs

Jaz Lyons-Reid (J)

Liggins Institute, The University of Auckland, Private Bag 92019, Auckland, New Zealand.

Timothy Kenealy (T)

Liggins Institute, The University of Auckland, Private Bag 92019, Auckland, New Zealand.
Department of Medicine and Department of General Practice and Primary Health Care, The University of Auckland, Auckland, New Zealand.

Benjamin B Albert (BB)

Liggins Institute, The University of Auckland, Private Bag 92019, Auckland, New Zealand.

Kate A Ward (KA)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Nicholas Harvey (N)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Keith M Godfrey (KM)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Shiao-Yng Chan (SY)

Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Wayne S Cutfield (WS)

Liggins Institute, The University of Auckland, Private Bag 92019, Auckland, New Zealand. w.cutfield@auckland.ac.nz.
A Better Start-National Science Challenge, The University of Auckland, Auckland, New Zealand. w.cutfield@auckland.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH